Description |
Product Type |
Product Size |
Injection |
5'S |
Product Company |
Novartis Pharma |
Ondansetron 8mg/4ml
|
Product Type |
Product Size |
Product Company |
Injection |
1'S |
AJM Pharmaceuticals |
|
Product Type |
Product Size |
Tablet |
10'S |
Product Company |
Pharmedic |
Ondansetron 8mg
|
Product Type |
Product Size |
Product Company |
Injection |
1'S |
Aqvida |
|
Product Type |
Product Size |
Tablet |
20'S |
Product Company |
Mass Pharma |
Amlodipine 5mg
|
Product Type |
Product Size |
Injection |
1'S |
Product Company |
Himmel Pharma
|
Carboplatin 150mg/15ml |
Content | Ondansetron is used to prevent nausea and vomiting caused by cancer chemotherapy, radiation therapy, and surgery.
| Gemcitabine is a nucleoside metabolic inhibitor used as adjunct therapy in the treatment of certain types of ovarian cancer, non-small cell lung carcinoma, metastatic breast cancer, and as a single agent for pancreatic cancer. | For prevention of nausea , vomiting associated with emetogenic chemotherapy, including high dose cisplatin and radiotherapy.
| Oxaliplatin is a platinum-based chemotherapy drug in the same family as cisplatin and carboplatin. It is typically administered in combination with fluorouracil and leucovorin in a combination known as Folfox for the treatment of colorectal cancer. Compared to cisplatin the two amine groups are replaced by cyclohexyldiamine for improved antitumour activity. The chlorine ligands are replaced by the oxalato bidentate derived from oxalic acid in order to improve water solubility. | Amlodipine is in a class of medications called calcium channel blockers. It lowers blood pressure by relaxing the blood vessels so the heart does not have to pump as hard. It controls chest pain by increasing the supply of blood to the heart
| Carboplatin is an alkylating agent used to treat advanced ovarian cancer.Carboplatin is indicated in combination with an established combination of chemotherapeutic agents for the initial treatment of advanced ovarian carcinoma. Carboplatin is also indicated for the palliative treatment of ovarian carcinoma, recurrent after prior chemotherapy.
|
Reviews
There are no reviews yet.